Table 3 Cumulative cost of medical-care services among patients with lung cancer receiving chemotherapy
From: Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
| Â | Mean (USD)(%) | |
|---|---|---|
| Â | n = 4068 | |
Inpatient | Â | Â |
   Acute hospital | 24,619 | 19.6% |
Outpatient Services* | Â | Â |
   Emergency Room | 802 | 0.6% |
   Physician Office/Hospital Outpatient |  |  |
Evaluation and Management | 2,436 | 1.9% |
Laboratory | 1,227 | 1.0% |
Radiology Diagnostic | 6,881 | 5.5% |
Radiology Therapeutic | 6,054 | 4.8% |
Nuclear Medicine | 838 | 0.7% |
All Surgery/Anesthesia | 1,654 | 1.3% |
Blood & Transfusion | 144 | 0.1% |
Physical & Occupational Therapy | 143 | 0.1% |
Medical & Surgical Supplies | 697 | 0.6% |
Chemo administration | 2,054 | 1.6% |
Mental health-care | 25 | 0.0% |
Other | 14,274 | 11.3% |
Subtotal | 36,426 | 28.9% |
   Home Health/Hospice/Skilled Nursing | 1,531 | 1.2% |
   Other | 4,291 | 3.4% |
   Total | 43,050 | 34.2% |
Medication | Â | Â |
   Chemotherapy | 27,924 | 22.2% |
   G-CSF | 2,968 | 2.4% |
   ESAs | 4,526 | 3.6% |
   Pain, sedatives, antidepressants | 1,693 | 1.3% |
   Anti-infectives | 345 | 0.3% |
   Anti-emetics | 2,500 | 2.0% |
   Bisphosphonates | 1,133 | 0.9% |
   Biologics | 2,783 | 2.2% |
   Gastrointestinal | 536 | 0.4% |
   Electrolytes, Caloric, Water | 58 | 0.0% |
   Cardiovascular | 606 | 0.5% |
   Blood products & Anticoagulants | 976 | 0.8% |
   Other | 12,132 | 9.6% |
Total | 58,179 | 46.2% |
TOTAL | 125,849 | 100.0% |